ProfessionalHybridActive

COMPASS Therapist Training Programme

The COMPASS Therapist Training Programme provides evidence-based training for mental health professionals working with COMP360 psilocybin therapy. It combines online theory, in-person practical skills training, and ongoing mentoring.

Provider

Details

10 hours
2 modules
Next cohort: Jul 13, 2026

Enrollment

Upcoming Cohort

Start date: July 13, 2026

Course Overview

The COMPASS Therapist Training Programme offers an evidence-based approach to psychotherapy training designed by leaders in psychology, psychiatry, and psychedelic therapy research. This programme equips mental health professionals with cutting-edge knowledge and practical skills for conducting COMP360 psilocybin therapy.

Designed for active, licensed mental health professionals, including clinical psychologists, clinical social workers, counsellors, and psychiatrists, the course fosters a deepened understanding of compassion, curiosity, openness, collaboration, presence, and cultural humility. The programme emphasizes developing a secure, genuine therapeutic relationship marked by trust, caring, confidentiality, and safety.

The curriculum is structured in a flexible, interactive format, including 10 hours of online theoretical learning, three days of in-person practical skills group training, and clinical training through recorded and live clinical sessions. By participating in this rigorous training, therapists will gain proficiency in leading sessions independently and achieve higher competency in their therapeutic skills.

Continuous professional development is supported through ongoing group mentoring, ensuring therapists stay at the forefront of therapeutic advancements. The programme is continuously revised and enhanced based on patient experiences and outcomes to ensure the highest quality of care.

Who is this for?

Active, licensed mental health professionals, including clinical psychologists, clinical social workers, counsellors, and psychiatrists.

Prerequisites

Active, licensed mental health professional.

About the Provider

COMPASS Pathways is a UK-listed biopharmaceutical company developing COMP360 synthetic psilocybin therapy for treatment-resistant depression, with two successful Phase 3 trials making it the leading candidate for the first regulatory approval of a classic psychedelic medicine.

View COMPASS Pathways profile

Course Details

  • Price$1,500
  • FormatHybrid
  • Lifecycle statusActive
  • Skills
    theoretical learningpractical trainingindependent session leadingprofessional developmentpatient-centred carecultural humilitycompassionate therapyevidence-based approachtherapeutic relationship buildingobservational learningongoing mentoringclinical proficiencygroup collaborationIntegration
  • Categories